CRA advanced analytics was hired by a pharmaceutical company to assess the impact of Covid-19 on the forecast of their pulmonology product in the US. Using the client’s geographical-level internal sales data, combined with publicly available coronavirus metrics, we were able estimate the trend to their product demand, segmented by state-level Covid-19 severity. The team’s findings were presented to the company’s leadership and board of investors, where the analysis was praised for its technical merit and sophistication in providing data-driven guidance surrounding the level of potential risk to their business.
Why diabetes and other common health conditions matter for men on prostate cancer hormone therapy
Key takeaways Men with prostate cancer are more likely to die from heart disease, not cancer. Patients who start androgen deprivation therapy (ADT) are...